Patents by Inventor Eric Jon Jacobsen

Eric Jon Jacobsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted-aryl compounds for treatment of disease
    Publication number: 20030236279
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: February 10, 2003
    Publication date: December 25, 2003
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Jason K. Myers, Vincent E. Groppi
  • Azabicyclic compounds for the treatment of disease
    Publication number: 20030232853
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: February 13, 2003
    Publication date: December 18, 2003
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Vincent E. Groppi
  • Substituted azepino[4,5b]indoline derivatives
    Publication number: 20030225058
    Abstract: The invention provides compounds of Formula (I): 1
    Type: Application
    Filed: March 20, 2003
    Publication date: December 4, 2003
    Applicant: Pharmacia & UpJohn Company
    Inventors: Kristine E. Frank, Brad A. Acker, Michael D. Ennis, Jed F. Fisher, Jian-Min Fu, Eric Jon Jacobsen, William W. McWhorter, Jeanette K. Morris, Donald Joseph Rogier
  • Bis-arylsulfones
    Publication number: 20030225065
    Abstract: The present invention provides pharmaceutically active compounds useful for the treatment of diseases or disorders of the central nervous system.
    Type: Application
    Filed: December 19, 2002
    Publication date: December 4, 2003
    Inventors: Eric Jon Jacobsen, Stephen J. King
  • Substituted azepino[4,5b]indole derivatives
    Publication number: 20030220321
    Abstract: Disclosed are compounds of Formula (I): 1
    Type: Application
    Filed: March 20, 2003
    Publication date: November 27, 2003
    Applicant: Pharmacia & UpJohn Company
    Inventors: Kristine E. Frank, Brad A. Acker, Michael D. Ennis, Jed F. Fisher, Jian-Min Fu, William W. McWhorter, Jeanette K. Morris, Donald Joseph Rogier, Eric Jon Jacobsen
  • Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
    Publication number: 20030207913
    Abstract: The invention provides compounds of Formula I:
    Type: Application
    Filed: November 6, 2002
    Publication date: November 6, 2003
    Inventors: David W. Piotrowski, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, Alice L. Bodnar, Vincent E. Groppi, Daniel Patrick Walker, Brad A. Acker
  • Bis-arylsulfones
    Publication number: 20030207866
    Abstract: The present invention provides pharmaceutically active compounds useful for the treatment of diseases or disorders of the central nervous system.
    Type: Application
    Filed: April 15, 2003
    Publication date: November 6, 2003
    Applicant: Pharmacia & Upjohn Company
    Inventors: Eric Jon Jacobsen, Stephen J. King
  • N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
    Publication number: 20030176702
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: October 17, 2002
    Publication date: September 18, 2003
    Inventors: Daniel Patrick Walker, Eric Jon Jacobsen, David W. Piotrowski, Brad A. Acker, Donn G. Wishka, Jeffrey W. Corbett, Mark R. Rauckhorst, Vincent E. Groppi
  • Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
    Publication number: 20030153595
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: October 1, 2002
    Publication date: August 14, 2003
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Donn G. Wishka, Steven Charles Reitz, Vincent E. Groppi
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Patent number: 6599916
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: July 29, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi, Jr., David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Azabicyclic-phenyl-fused-heterocyclic compounds for treatment of disease
    Publication number: 20030130305
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: November 1, 2002
    Publication date: July 10, 2003
    Inventors: Daniel Patrick Walker, David W. Piotrowski, Eric Jon Jacobsen, Brad A. Acker, Vincent E. Groppi
  • Bis-arylsulfones
    Patent number: 6586592
    Abstract: The present invention provides pharmaceutically active compounds useful for the treatment of diseases or disorders of the central nervous system.
    Type: Grant
    Filed: October 2, 2001
    Date of Patent: July 1, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Eric Jon Jacobsen, Stephen J. King, Kalpana M. Merchant
  • Substituted azepino[4,5b]indoline derivatives
    Patent number: 6586421
    Abstract: The invention provides compounds of Formula (I): wherein R1-R4, p and q have any of the values described in the specification, as well as pharmaceutical salts thereof, and pharmaceutical compositions containing such compounds or salts. The compounds and salts are 5-HT ligands and are useful for treating diseases, disorders, and/or conditions in a mammal wherein activity of a 5-HT receptor is implicated. The compounds and salts are particularly useful for treating diseases of the central nervous system.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: July 1, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Kristine E. Frank, Brad A. Acker, Michael D. Ennis, Jed F. Fisher, Jian-min Fu, Eric Jon Jacobsen, William W. McWhorter, Jr., Jeanette K. Morris, Donald Joseph Rogier
  • Substituted azepino[4,5b]indole derivatives
    Patent number: 6583135
    Abstract: Disclosed are compounds of Formula (I): wherein R1-R4, p and q have any of the values described in the specification, as well as pharmaceutical salts thereof, and pharmaceutical compositions containing such compounds or salts. The compounds and salts are 5-HT ligands and are useful for treating diseases, disorders, and/or conditions in a mammal wherein activity of a 5-HT receptor is implicated. The compounds and salts are particularly useful for treating diseases of the central nervous system.
    Type: Grant
    Filed: September 20, 2001
    Date of Patent: June 24, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Kristine E. Frank, Brad A. Acker, Michael D. Ennis, Jed F. Fisher, Jian-min Fu, William W. McWhorter, Jr., Jeanette K. Morris, Donald Joseph Rogier, Eric Jon Jacobsen
  • Bis-arylsulfones
    Patent number: 6579870
    Abstract: The present invention provides pharmaceutically active compounds useful for the treatment of diseases or disorders of the central nervous system.
    Type: Grant
    Filed: June 8, 2001
    Date of Patent: June 17, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Eric Jon Jacobsen, Stephen J. King
  • Substituted-heteroaryl-7-aza[2.2.1]bicycloheptanes for the treatment of disease
    Patent number: 6562816
    Abstract: The invention provides compounds of Formula I: compounds of the Formula I: wherein R1, R2, R4, R6, X, and W are defined herein. These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals used to treat diseases or conditions in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 14, 2002
    Date of Patent: May 13, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Donn G. Wishka, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, David W. Piotrowski, Jeffrey W. Corbett, Alice L. Bodnar, Vincent E. Groppi, Jr.
  • SUBSTITUTED-HETEROARYL-7-AZA[2.2.1] BYCYCLOHEPTANES FOR THE TREATMENT OF DESEASE
    Publication number: 20030069290
    Abstract: The invention provides compounds of Formula I: compounds of the Formula I: 1
    Type: Application
    Filed: August 14, 2002
    Publication date: April 10, 2003
    Inventors: Donn G. Wishka, Jason K. Myers, Bruce N. Rogers, Eric Jon Jacobsen, David W. Piotrowski, Jeffrey W. Corbett, Alice L. Bodnar, Vincent E. Groppi,
  • Substituted azabicyclic moieties for the treatment of disease
    Publication number: 20030055043
    Abstract: The invention provides compounds of Formula I: 1
    Type: Application
    Filed: April 17, 2002
    Publication date: March 20, 2003
    Inventors: Eric Jon Jacobsen, Daniel Patrick Walker, Jason K. Myers, David W. Piotrowski, Vincent E. Groppi
  • Quinuclidine-substituted heteroaryl moieties for treatment of disease
    Patent number: 6500840
    Abstract: The invention provides compounds of Formula I: These compounds may be in the form of pharmaceutical salts or compositions, and racemic mixtures or pure enantiomers thereof. The compounds of Formula I are useful in pharmaceuticals in which &agr;7 is known to be involved.
    Type: Grant
    Filed: August 17, 2001
    Date of Patent: December 31, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Jason K. Myers, Bruce N. Rogers, Vincent E. Groppi, Jr., David W. Piotrowski, Alice L. Bodnar, Eric Jon Jacobsen, Jeffrey W. Corbett
  • Tetracyclic azepinoindole compounds
    Publication number: 20020198190
    Abstract: The present invention provides compounds of formula I: 1
    Type: Application
    Filed: June 17, 2002
    Publication date: December 26, 2002
    Applicant: PHARMACIA & UPJOHN COMPANY
    Inventors: Jackson B. Hester, Bruce N. Rogers, Eric Jon Jacobsen, Michael D. Ennis, Brad A. Acker, Susan L. Vander Velde, Kristine E. Frank